To facilitate the direct study of progenitor cell biology, we have developed a simple and efficient procedure based upon negative selection by panning to purify large numbers of committed erythroid and myeloid progenitors from human fetal liver. The nonadherent, panned cells constitute a highly enriched population of progenitor cells, containing 30.4±13.1% erythrocyte burst forming units (BFU-E), 5.5±1.9% granulocyte-macrophage colony forming units (CFU-GM), and 1.4±0.7% granulocyte-erythroid-macrophage-megakaryocyte colony forming units (CFU-GEMM) as assayed in methylcellulose cultures. These cells are morphologically immature blasts with prominent Golgi. This preparative method recovers 60-100% of the committed progenitors detectable in unfractionated fetal liver and yields 2-30 X 106 progenitors from each fetal liver sample, and thus provides sufficient numbers of enriched progenitors to allow direct biochemical and immunologic manipulation. Using this technique, a purified recombinant protein previously thought to have only granulocyte-macrophage colony stimulating activity (GM-CSA) is shown to have both burst promoting activity and multipotential colony stimulating activity. Progenitor purification by panning thus appears to be a simple, efficient method that should facilitate the direct study of committed hematopoietic progenitors and their differentiation.
Introduction
The cellular and molecular analysis of hematopoietic regulation has been hindered by the extreme rarity of the critical hematopoietic progenitor cells in the bone marrow and peripheral blood (1, 2, 3) . Identification and accurate characterization of colony stimulating activities have been particularly difficult due to the endogenous production of these activities by accessory cells that contaminate the progenitor cells isolated by current techniques. Thus, a source of purified progenitors and purified factors would be invaluable for the accurate analysis of hematopoietic regulation. Approaches to the purification of progenitor cells have included differential density centrifugation (4) and density gradient electrophoresis (5), immune selection using rosetting (6) or fluorescence-activated cell sorting (7, 8) , and various combinations of these physical and immunologic techniques (9) .
While these techniques have led to a significant progenitor enrichment, cell yields have been notably low, particularly when the prefractionation sample consists of normal, nonneoplastic human hematopoietic cells. This limitation has restricted biochemical analysis of the enriched progenitors, and has prevented detailed studies of growth factor and accessory cell interactions with human progenitor cells.
We have therefore developed a simple and efficient procedure to purify large numbers of human erythroid and myeloid progenitors. Beginning with fetal liver cells (10, 1 1, 12) and utilizing negative selection by panning (13, 14, 15) , the technique greatly enriches the progenitor cells and provides, for the first time, sufficient numbers of progenitors to allow direct morphological and biochemical studies ofthese cells. In this report, we describe this progenitor purification technique, we present preliminary morphologic analysis of the progenitors, and we show that a purified recombinant protein initially characterized as granulocyte-macrophage colony stimulating activity (GM-CSA) (16) in fact possesses both burst promoting activity (BPA)' and multipotential colony stimulating activity (multi-CSA). (19) . Granulocyte-macrophage colony forming units (CFU-GM) and granulocyte-erythroid-macrophage-megakaryocyte colony forming units (CFU-GEMM) were assayed by culturing the cells in the presence of 10% vol/vol Mo conditioned medium as well. Red colonies (usually containing over 1,000 cells and always at least 100 cells) present on day 14 were scored as BFU-E; colonies containing nonhemoglobinized cells (primarily granulocytic precursors and macrophages) were scored as CFU-GM, while colonies containing both erythroid elements and one or more classes of phagocytic on megakaryocytic cells were scored as CFU-GEMM. Demonstration of GM-CSA, BPA, and multi-CSA. Recombinant colony stimulating activity cloned and purified from the complementary DNA (cDNA) of the Mo cell line was prepared as previously described (16) . Briefly, a cDNA library was derived from messenger RNA (mRNA) of lectin-stimulated Mo cells, and active clones coding for colony stimulating activity (CSA) were detected by transfection of monkey COS-I cells. The recombinant CSA was then purified from serum-free COS-l supernatants by gel filtration and high performance liquid chromatography. GM-CSA, BPA, and multi-CSA were assayed on the final purified progenitor fraction by initiating methylcellulose cultures in the presence of graded concentrations of the HPLC purified recombinant protein, and after 3 d I U/ml erythropoietin was added to each replicate (20, 21) . No additional source of BPA or CSA was included in the cultures.
Methods
BFU-E, CFU-C, and CFU-GEMM were enumerated on day 14, as before.
Results
Cell recovery and analysis through the fractionation. The fetal progenitor purification schema, with two ficoll gradients, one adherence depletion, and a final immune depletion by panning, is shown in Fig. 1 The majority of the progenitors present in the original fetal liver mononuclear cell suspension were recovered throughout the fractionation procedure. In the final fraction, after double ficoll separation, adherence depletion and panning, 88±10% of BFU-E, 62±20% of CFU-GM, and 98±10% of CFU-GEMM were recovered. Thus, the 2-60 X 106 cells obtained from each fractionation contained most of the progenitors present in the original fetal liver.
Linear plating efficiency to low cell concentration. This high degree ofprogenitor purity permitted short-term in vitro culture at low cell density (Fig. 2) . Cells obtained after the first ficoll step were routinely cultured at 105 cells/ml, and could only be diluted to 104 cells/ml while still retaining normal growth characteristics. Below this concentration the colonies which began to develop disintegrated a few days into the culture. Cells obtained after a second gradient separation and adherence depletion could be cultured over a range of from 103_-10 cells/ml with linear plating characteristics.
The highly enriched progenitors isolated after panning could be cultured at 102-104 cells/ml while maintaining qualitatively normal colony growth and linear plating characteristics. When cultured at higher density, the colonies overlapped in the plates and could not be accurately enumerated. When the cells were plated at <102/ml (10-25 cells per well), colony growth was poor, with only small poorly differentiated colonies that disintegrated prematurely. Initial characterization ofthepurifiedprogenitors. Sufficient quantities of purified progenitors were thus obtained to permit direct morphological and histochemical characterization of these cells. When stained with routine Wright-Giemsa, the cells appeared to be undifferentiated blasts of variable size with basophilic cytoplasm, prominent Golgi zones, and often containing multiple nucleoli. In addition, the cell membranes showed many small areas of extrusion suggesting uropod formation (Fig. 3 ). There were no detectable cells resembling small lymphocytes, and as expected, only very rare contaminating recognizable erythroid or myeloid precursors were found. The panned progenitor cells did not stain with standard histochemical dyes, including myeloperoxidase, periodic acid-Schiff, nonspecific esterase, alkaline phosphatase, and acid phosphatase.
Detection of BPA and multi-CSA in recombinant protein. These highly enriched progenitors were then used to detect the range of myeloid stimulating activities present in a purified recombinant protein cloned from the Mo cell line (16) , which was initially thought to have only a restricted GM-CSA. Short-term cultures were initiated in methylcellulose without erythropoietin, which was added on day three. Under these conditions no colonies developed, as all of the accessory cells that contribute to the survival and proliferation of the progenitor cells had been removed and no exogenous source of BPA or CSA (e.g. Mo CM) had been added (Fig. 4) . However, when the recombinant protein was added at the initiation of the cultures, erythroid bursts and mixed GEMM colonies as well as purely myeloid colonies were detected. Maximal BPA was detectable with as little as 1 ng/ml added recombinant protein, and both BPA and multi-CSA were detectable with as little as 10 pg/ml. The use of purified progenitors depleted of known accessory cells thus results in extremely low background that permits the detection of BPA and multi-CSA in this protein. Figure 3 . Wright-Giemsa stain of the panned progenitor cells. Note the prominent Golgi, nucleoli, and membrane exfoliation. Colony frequencies from this particular preparation were: BFU-E, 39%; CFU-GM, 9.5%; CFU-GEMM, 1.5%.
Discussion
This technique provides a superior method for the isolation of large numbers ofhighly enriched, relatively unmanipulated progenitors. Of note, the calculated progenitor frequency of 22-75% may be an underestimate of the actual number of progenitors present in the final fraction, due to the limitations of in vitro culture per se. Visser et al. (22) have found that murine progenitor cells which they calculate to be 100% in vivo primary CFU-S have only a 25-30% plating efficiency in vitro. Ogawa and his colleagues (23) have found that the replating efficiency in methylcellulose of observable, dividing colony progenitors is only 50-75%. Thus the actual frequency of progenitors in the post-panning fraction may be closer to 50-100%, with the lower observed frequency due to the imperfect plating efficiency of the methyl cellulose system itself.
Panning for negative selection has several advantages over other techniques for progenitor purification. Unlike rosetting (6, 24, 25) or complement mediated lysis, panning involves no potential nonspecific toxins, such as CrCl3 or complement, which can damage the progenitors. This is extremely important for normal progenitors, which we have found are quite sensitive to nonspecific damage by CrCl3-coupled erythrocytes used for rosetting, unlike leukemic progenitors, which may be somewhat more resistant. Moreover, the panning procedure is based on the labeling ofonly undesired cells, without direct manipulation ofthe progenitors themselves. Thus, the in vitro behavior ofthe recovered progenitors is unlikely to be artifactually influenced by the antibody treatment per se. Finally, panning is very simple and easy to perform, and results in an extremely high yield of recovered progenitors. In these respects it is superior to multiparameter fluorescence-activated cell sorting, for example, which requires sophisticated equipment and still results in typical cell yields of only 20-50%.
The isolated progenitors appear to be basophilic, undifferentiated blasts with prominent Golgi zones and frequent membranous extrusions. The active Golgi suggests that these cells are actively synthesizing membrane glycoproteins, likely including membrane receptors for hematopoietic growth factors. Thus these cells might be an excellent cell population for identification and study ofsuch receptors. The unusual folded membrane may reflect submembranous cytoskeletal structures responsible for the immature progenitors' motility, which are responsible for the multicentric nature of erythroid bursts and multilineage colonies.
Ideally, one would like to be able to culture these progenitors at limiting dilution to address directly questions such as the role of soluble factors, and auxiliary cells in altering the stochastic program ofdifferentiating progenitors. So far, however, we have only succeeded in routinely culturing these cells at 100 cells/ml (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (25) .
The high progenitor concentration and the lack of T cells, monocytes, and other cells known to produce hematopoietic growth factors allow the purified progenitor pool to be an extremely sensitive and accurate test population for assaying the activity of soluble factors and defined cell populations. In this study these purified progenitors were used to demonstrate that a purified recombinant protein previously thought to have only limited GM-CSA in fact processes both BPA and multi-CSA. Removing the active accessory cells was in fact essential to demonstrating the full spectrum of activity of the recombinant CSA molecule.
-Although this protein has -60% DNA sequence homology with murine granulocyte-macrophage colony stimulating factor (GM-CSF) and none with murine interleukin-3 (IL-3) (16), its activity resembles that of murine IL-3. Inasmuch as no human DNA sequences homologous to murine IL-3 have yet been detected, it is possible that during evolution the human GM-CSA gene has taken over the multipoietin role characteristic of IL-3 in the mouse. It will be of interest to determine, once their DNA and protein sequences are known, whether molecules with putative multipotential CSA purified from other sources (26) are identical to the protein analyzed in this study, and to measure the full target cell specificities and phylogenetic ranges ofactivities of these hormones.
This method for progenitor purification should prove to be extremely valuable for the further study of the regulation of hematopoiesis. The preparations provide, for the first time, sufficient normal cells for the direct biochemical isolation of human progenitor membrane proteins, including membrane receptors for such proteins as erythropoietin and multipotential CSA. Similarly, the purified progenitors are an ideal immunogen and screening cell source for the generation and detection of antibodies truly specific for hematopoietic progenitors. Purification by panning is thus a simple, highly efficient technique for the isolation of fetal liver progenitors, and is a valuable tool for improving our understanding of the molecular and cellular regulation of human hematopoiesis.
